4[2]Englund K,Blanck A,Gustarsson I,et al. Sex steroid receptors in human myometrium and fibroids :Changes during the menstrual cycle and gonadotropin_ releasing hormone treatment[J]. Clin Endocrinol Metab, 1998,83 : 4 092～ 4 096
5[4]Filicori M. A Conservative approach to the management of uterine leiomyoma:Pituitary desenstitization by a Luteinizing hormone_releasing analogue[J]. An J Obster Gynecol, 1983,147:726
7[7]Palomba S,Affinito P,Tommaselli GA,et al. A clinical trial of the effects of tibolone administered with gonadotropinreleasing hormone analogues for the treatment of uterine leiomyomata [J]. Fertil Steril, 1998,70 (1): 111 ～ 118
8[9]Murphy AA, Kettel LM, Morales AJ, et al. Regression of uterine Leiomyoma in response to the antiprogesterone RU486[J]. J Clin Endocrinol Metab,1993,76(2) :513～517
9[19]Harima Y, Harima K, Hasegawa T, et al. Histopathological changes in rabbit uterus carcinoma after transcatheterarterial embolization using cisplatin[J]. Cancer Chemother Pharmacol, 1996,38(4): 317～322
10[20]Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolisation to treat uterine myomata [ J]. Lancet,1995,346(8 976):671～672
